-
Something wrong with this record ?
Topical treatment modalities for old world cutaneous leishmaniasis: A review
Alavi-Naini R., Fazaeli A., O'Dempsey T.
Language English Country Czech Republic
Document type Review
NLK
Directory of Open Access Journals
from 2012
Medline Complete (EBSCOhost)
from 2012-01-01
- MeSH
- Amphotericin B administration & dosage adverse effects therapeutic use MeSH
- Antimony therapeutic use MeSH
- Administration, Cutaneous MeSH
- Administration, Topical MeSH
- Phototherapy methods utilization MeSH
- Imidazoles administration & dosage therapeutic use MeSH
- Hyperthermia, Induced methods utilization MeSH
- Cryotherapy methods utilization MeSH
- Laser Therapy methods utilization MeSH
- Leishmaniasis, Cutaneous diagnosis etiology therapy MeSH
- Humans MeSH
- Naphthoquinones administration & dosage therapeutic use MeSH
- Organometallic Compounds therapeutic use MeSH
- Paromomycin administration & dosage therapeutic use MeSH
- Primaquine analogs & derivatives administration & dosage therapeutic use MeSH
- Plant Extracts therapeutic use MeSH
- Therapeutics classification methods utilization MeSH
- Toll-Like Receptor 7 administration & dosage therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Review MeSH
Diagnosis and therapy of cutaneous leishmaniasis (CL) can be difficult due to the variability of the clinical pictures and resistance to therapy. There is no vaccine currently available for CL. The aim of the present review is to describe different topical treatment modalities for old world CL. The mainstays of treatment for old world CL are pentavalent antimony compounds which are administered parenterally or intralesionally. New topical treatment alternatives have been available within the past few years. Amongst several treatments used topically, physical therapies including cryotherapy, heat therapy and CO2 laser are promising for the treatment of old world CL. Along with that, other randomized placebo controlled trials should be designed to find new effective therapeutic regimens.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022627
- 003
- CZ-PrNML
- 005
- 20121005124640.0
- 007
- ta
- 008
- 120806s2012 xr f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.14712/23362936.2015.26 $2 doi
- 035 __
- $a (PubMed)22691282
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Alavi-Naini, R. $u Research Centre for Infectious Diseases and Tropical Medicine, Zahedan University of Medical Sciences, Zahedan, Iran $7 gn_A_00003330
- 245 10
- $a Topical treatment modalities for old world cutaneous leishmaniasis: A review / $c Alavi-Naini R., Fazaeli A., O'Dempsey T.
- 504 __
- $a Literatura
- 520 9_
- $a Diagnosis and therapy of cutaneous leishmaniasis (CL) can be difficult due to the variability of the clinical pictures and resistance to therapy. There is no vaccine currently available for CL. The aim of the present review is to describe different topical treatment modalities for old world CL. The mainstays of treatment for old world CL are pentavalent antimony compounds which are administered parenterally or intralesionally. New topical treatment alternatives have been available within the past few years. Amongst several treatments used topically, physical therapies including cryotherapy, heat therapy and CO2 laser are promising for the treatment of old world CL. Along with that, other randomized placebo controlled trials should be designed to find new effective therapeutic regimens.
- 650 _2
- $a leishmanióza kožní $x diagnóza $x etiologie $x terapie $7 D016773
- 650 _2
- $a terapie $x klasifikace $x metody $x využití $7 D013812
- 650 _2
- $a aplikace lokální $7 D000287
- 650 _2
- $a aplikace kožní $7 D000279
- 650 _2
- $a antimon $x terapeutické užití $7 D000965
- 650 _2
- $a organokovové sloučeniny $x terapeutické užití $7 D009942
- 650 _2
- $a kryoterapie $x metody $x využití $7 D017679
- 650 _2
- $a amfotericin B $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D000666
- 650 _2
- $a imidazoly $x aplikace a dávkování $x terapeutické užití $7 D007093
- 650 _2
- $a paromomycin $x aplikace a dávkování $x terapeutické užití $7 D010303
- 650 _2
- $a primachin $x analogy a deriváty $x aplikace a dávkování $x terapeutické užití $7 D011319
- 650 _2
- $a naftochinony $x aplikace a dávkování $x terapeutické užití $7 D009285
- 650 _2
- $a toll-like receptor 7 $x aplikace a dávkování $x terapeutické užití $7 D051199
- 650 _2
- $a indukovaná hypertermie $x metody $x využití $7 D006979
- 650 _2
- $a fototerapie $x metody $x využití $7 D010789
- 650 _2
- $a laserová terapie $x metody $x využití $7 D053685
- 650 _2
- $a rostlinné extrakty $x terapeutické užití $7 D010936
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Fazaeli, Asghar $u Department of Parasitology, School of Medicine, Zanjan University of Medical Sciences and Health Services, Zanjan, Iran
- 700 1_
- $a O'Dempsey, T. $u Liverpool School of Tropical Medicine, Liverpool, UK
- 773 0_
- $t Prague medical report $x 1214-6994 $g Roč. 113, č. 2 (2012), s. 105-118 $w MED00013414
- 856 41
- $u https://pmr.lf1.cuni.cz/media/pdf/pmr_2012113020105.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 7 $c 1071 $y 2
- 990 __
- $a 20120806085423 $b ABA008
- 991 __
- $a 20121005124828 $b ABA008
- 999 __
- $a ok $b bmc $g 944540 $s 779925
- BAS __
- $a 3
- BMC __
- $a 2012 $b 113 $c 2 $d 105-118 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
- LZP __
- $a 2012-14/mkal